BioCentury | Jan 6, 2014
Company News

Taiwan Liposome, Novartis sales and marketing update

...On Dec. 18, 2013, Taiwan Liposome granted Novartis' Sandoz AG generics unit rights to commercialize AmBiL...
...early 2014. Yung Shin Pharmaceutical Industrial Co. Ltd. (Taiwan:1716, Taichung, Taiwan) has commercialization rights to AmBiL...
BioCentury | Jul 29, 2013
Company News

Taiwan Liposome sales and marketing update

...Taiwan Liposome launched AmBiL amphotericin B - a generic version of antifungal drug AmBisome from Gilead...
...of AmBisome, including 4,590 vials in Taiwan, after bacterial contamination was discovered. Taiwan Liposome said AmBiL...
...50 mg vial, which the company said is the same price as AmBisome. Doses of AmBiL...
BioCentury | Jul 15, 2013
Clinical News

AmBiL regulatory update

...Product: AmBiL Business: Infectious Taiwan Liposome said Taiwan approved AmBiL to treat systemic fungal infection. AmBiL...
...of amphotericin B. Yung Shin Pharmaceutical Industrial Co. (Taiwan:1716, Taichun, Taiwan) has distribution rights to AmBiL...
Items per page:
1 - 3 of 3